{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "increases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ06261",
      "entity_text" : "muL MOG",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uniprot:Q03547",
      "entity_text" : "EAE",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "EAE was actively induced by subcutaneously injecting 250 muL MOG 35-55 peptide (ProImmune Ltd.) emulsified in IFA (Sigma) supplemented with 250 muL mycobacterium tuberculosis extract H37Ra (Difco).",
  "reading_complete" : "2020-08-08T11:47:06Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-08T11:44:44Z",
  "trigger" : "induced",
  "evidence" : [ "EAE was actively induced by subcutaneously injecting 250 muL MOG" ],
  "pmc_id" : "5483510",
  "score" : 0
}